Tag:
Sequenom
Latest Headlines
Latest Headlines
Sequenom announces availability of MaterniT21 LDT
The Sequenom Center for Molecular Medicine has launched its noninvasive MaterniT21 laboratory developed test (LDT) to detect Trisomy 21, the most common cause of Down syndrome. The MaterniT21 LDT is
Sequenom axes top execs following scandal probe
Sequenom has axed a group of its top executives, including its CEO, after concluding an internal investigation into a scandal revolving around their handling of data on a prenatal test the biotech
Sequenom cuts 30 in genetic analysis
Sequenom is laying off 30 people in its genetic analysis unit. "These actions are difficult but essential," Sequenom CEO Harry Stylli said in a statement. "While we remain optimistic that the outlook
Exact Sciences inks $24M sale, fends off hostile bid
Exact Sciences has forged an asset sale agreement with Genzyme for $24.5 million in a deal that successfully fended off a hostile buyout offer from Sequenom. Genzyme gets IP concerning prenatal and
Sequenom gets hostile in Exact Sciences bid
Sequenom isn't taking 'no' for an answer to its bid to acquire Exact Sciences. The company announced this morning that its earlier offer to buy the cancer test developer--which had been rejected--is
Exact Sciences spurns Sequenom acquisition bid
EXACT Sciences has firmly rejected Sequenom's $41 million offer to buy the company. Instead, the cancer test maker says it is pursuing a "strategic alternative" that will be better for shareholders.
Sequenom plans Grand Rapids lab expansion
Sequenom won $20 million in grants from the state of Michigan as it completes a deal to buy a lab in Grand Rapids and expand the operations, bringing more than 500 new jobs to the economically
